In a statement, a NextGen spokeperson toldEHRIntelligence,“The Company denies that any of its conduct violated the law, and the settlement agreement does not include any admissions of wrongdoing. This agreement relates to claims from more than a decade ago.” “The settlement r...
I suggest that the principle of fair competition can distinguish between regulatory violations that should result in civil liability and those better handled within a preexisting regulatory regime. This clear, principled rule for liability can aid development of a fair, competitive marketplace not ...
The United States and the Commonwealth of Massachusetts investigated the allegations after three whistleblowers filed aFalse Claims Act complaintin the US District Court for the District of Massachusetts in 2018. The whistleblowers will receive 17 percent of the settlement amount. Stewar...
Pharmacy Law Brief: the Federal False Claims Act. Kentucky Pharmacist. 2014;9(4):40-41.5. Id.6. Ogrosky K, Shuren AW. The most challenging compliance arena in healthcare: pharmaceutical and medical device manufacturing compliance: professionals can take steps to better prepare ...
Section 3732. False claims jurisdiction (a) Actions under section 3730.–Any action under section 3730 may be brought in any judicial district in which the defendant or, in the case of multiple defendants, any one defendant can be found, resides, transacts business, or in which any act pros...
or so completely lacking in value or utility to a nursing facility patient, that a reasonable person would understand that any services provided were worthless. Services can be worthless, and the claims for those services can, for that reason, be false, even if the nursing facility in...
Food & Drug Administration (FDA) rules and False Claims Act violation. According to allegations, company officials never sough approval from the FDA for alternative uses of Neurontin.Hancock, Allyson CVenulex Legal Summaries
and the penalty adjustment applied only to violations that occurredafterthe date the adjustment took effect. To implement the amendments to the Adjustment Act, in 1999, DOJ published a rule increasing by 10 percent the civil penalties for false claims from the $5,000...
DOJ continued to pursue claims against several executives, including the former chief executive, alleging violations of the Controlled Substances Act.[18] On August 27, a hospital in Texas agreed to pay $3.3 million to settle a qui tam suit brought by its former Director of Compliance resolving...
(1st Cir. Feb. 18, 2025). In so holding, the First Circuit joined a circuit split on the meaning of the 2010 AKS amendment providing that claims “resulting from” AKS violations are false for purposes of the FCA (as previously discussedhere). Like the First Circuit, the Sixth and ...